GSK Investigational Site

Lappeenranta 53130

0 studies enrolling now · 6 studies all time

What they study most

Infections, Papillomavirus, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Sepsis

Studies at this site

• Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects — Completed
• Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed